Aptuit LLC and Axxam SpA have entered a strategic alliance to provide integrated drug discovery and development services from gene to candidates and beyond. Additionally, the companies’ began their first significant joint integrated project with a large pharma company.    Aptuit provides drug discovery and development services for early discovery to mid-phase and Axxam is a discovery company with expertise in target biology and a broad range of early phase discovery services.   Jonathan Goldman,...